Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis

This publication has 118 references indexed in Scilit:

• Association of arterial events with the coexistence of metabolic syndrome and primary antiphospholipid syndrome
  Arthritis Care & Research, 2012
• Pathogenesis of antiphospholipid syndrome: understanding the antibodies
  Nature Reviews Rheumatology, 2011
• Asymptomatic myocardial ischemic disease in antiphospholipid syndrome: A controlled cardiac magnetic resonance imaging study
  Arthritis & Rheumatism, 2010
• Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug
  Blood, 2010
• Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies
  Arthritis Care & Research, 2008
• Prevention of murine antiphospholipid syndrome by BAFF blockade
  Arthritis & Rheumatism, 2008
• Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction
  Rheumatology, 2008
• Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome
  Lupus, 2007
• Prevalence of an abnormal ankle-brachial index in patients with antiphospholipid syndrome with pregnancy loss but without thrombosis: a controlled study
  Annals of the Rheumatic Diseases, 2006
• Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data
  Annals of the Rheumatic Diseases, 2005